nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—Pulmonary embolism—Varenicline—nicotine dependence	0.0392	0.0612	CcSEcCtD
Flutamide—Diabetes mellitus—Varenicline—nicotine dependence	0.0327	0.0511	CcSEcCtD
Flutamide—Libido decreased—Varenicline—nicotine dependence	0.0307	0.0479	CcSEcCtD
Flutamide—Hot flush—Varenicline—nicotine dependence	0.0304	0.0475	CcSEcCtD
Flutamide—Increased appetite—Varenicline—nicotine dependence	0.0303	0.0473	CcSEcCtD
Flutamide—Menopausal symptoms—Varenicline—nicotine dependence	0.0301	0.0471	CcSEcCtD
Flutamide—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.0282	0.0441	CcSEcCtD
Flutamide—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0278	0.0773	CbGpPWpGaD
Flutamide—Erectile dysfunction—Varenicline—nicotine dependence	0.0226	0.0354	CcSEcCtD
Flutamide—Photosensitivity reaction—Varenicline—nicotine dependence	0.0224	0.035	CcSEcCtD
Flutamide—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0223	0.062	CbGpPWpGaD
Flutamide—Hyperglycaemia—Varenicline—nicotine dependence	0.0222	0.0346	CcSEcCtD
Flutamide—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.0211	0.0586	CbGpPWpGaD
Flutamide—Oedema peripheral—Varenicline—nicotine dependence	0.0194	0.0303	CcSEcCtD
Flutamide—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.0172	0.0479	CbGpPWpGaD
Flutamide—Erythema—Varenicline—nicotine dependence	0.0171	0.0267	CcSEcCtD
Flutamide—Ill-defined disorder—Varenicline—nicotine dependence	0.0159	0.0248	CcSEcCtD
Flutamide—Anaemia—Varenicline—nicotine dependence	0.0158	0.0247	CcSEcCtD
Flutamide—Malaise—Varenicline—nicotine dependence	0.0154	0.0241	CcSEcCtD
Flutamide—Hypertension—Varenicline—nicotine dependence	0.0148	0.0231	CcSEcCtD
Flutamide—Anxiety—Varenicline—nicotine dependence	0.0145	0.0227	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.0145	0.0226	CcSEcCtD
Flutamide—Discomfort—Varenicline—nicotine dependence	0.0144	0.0225	CcSEcCtD
Flutamide—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0142	0.0395	CbGpPWpGaD
Flutamide—CYP1B1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.014	0.039	CbGpPWpGaD
Flutamide—Oedema—Varenicline—nicotine dependence	0.014	0.0218	CcSEcCtD
Flutamide—Thrombocytopenia—Varenicline—nicotine dependence	0.0137	0.0214	CcSEcCtD
Flutamide—Skin disorder—Varenicline—nicotine dependence	0.0136	0.0212	CcSEcCtD
Flutamide—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.0134	0.0374	CbGpPWpGaD
Flutamide—Anorexia—Varenicline—nicotine dependence	0.0133	0.0208	CcSEcCtD
Flutamide—Insomnia—Varenicline—nicotine dependence	0.0126	0.0197	CcSEcCtD
Flutamide—Somnolence—Varenicline—nicotine dependence	0.0124	0.0194	CcSEcCtD
Flutamide—AHR—Circadian rythm related genes—CHRNB2—nicotine dependence	0.0123	0.0343	CbGpPWpGaD
Flutamide—Decreased appetite—Varenicline—nicotine dependence	0.0122	0.019	CcSEcCtD
Flutamide—Fatigue—Varenicline—nicotine dependence	0.0121	0.0188	CcSEcCtD
Flutamide—Constipation—Varenicline—nicotine dependence	0.012	0.0187	CcSEcCtD
Flutamide—CYP1B1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0115	0.032	CbGpPWpGaD
Flutamide—Feeling abnormal—Varenicline—nicotine dependence	0.0115	0.018	CcSEcCtD
Flutamide—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.0104	0.0288	CbGpPWpGaD
Flutamide—Asthenia—Varenicline—nicotine dependence	0.01	0.0157	CcSEcCtD
Flutamide—Pruritus—Varenicline—nicotine dependence	0.00989	0.0154	CcSEcCtD
Flutamide—Diarrhoea—Varenicline—nicotine dependence	0.00956	0.0149	CcSEcCtD
Flutamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00926	0.0258	CbGpPWpGaD
Flutamide—Dizziness—Varenicline—nicotine dependence	0.00924	0.0144	CcSEcCtD
Flutamide—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00914	0.0254	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—DRD2—nicotine dependence	0.00911	0.0253	CbGpPWpGaD
Flutamide—Vomiting—Varenicline—nicotine dependence	0.00889	0.0139	CcSEcCtD
Flutamide—Rash—Varenicline—nicotine dependence	0.00881	0.0138	CcSEcCtD
Flutamide—Dermatitis—Varenicline—nicotine dependence	0.00881	0.0138	CcSEcCtD
Flutamide—Headache—Varenicline—nicotine dependence	0.00876	0.0137	CcSEcCtD
Flutamide—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00875	0.0243	CbGpPWpGaD
Flutamide—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00864	0.024	CbGpPWpGaD
Flutamide—Nausea—Varenicline—nicotine dependence	0.0083	0.013	CcSEcCtD
Flutamide—AR—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00766	0.0213	CbGpPWpGaD
Flutamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00751	0.0209	CbGpPWpGaD
Flutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00716	0.0199	CbGpPWpGaD
Flutamide—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00709	0.0197	CbGpPWpGaD
Flutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00707	0.0196	CbGpPWpGaD
Flutamide—CYP1B1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00649	0.018	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—CYP2A7—nicotine dependence	0.00612	0.017	CbGpPWpGaD
Flutamide—CYP1B1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00604	0.0168	CbGpPWpGaD
Flutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00581	0.0161	CbGpPWpGaD
Flutamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00558	0.0155	CbGpPWpGaD
Flutamide—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00551	0.0153	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00511	0.0142	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00464	0.0129	CbGpPWpGaD
Flutamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00452	0.0126	CbGpPWpGaD
Flutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00431	0.012	CbGpPWpGaD
Flutamide—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00425	0.0118	CbGpPWpGaD
Flutamide—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00423	0.0118	CbGpPWpGaD
Flutamide—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.004	0.0111	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00399	0.0111	CbGpPWpGaD
Flutamide—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00393	0.0109	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00377	0.0105	CbGpPWpGaD
Flutamide—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00372	0.0103	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00349	0.00971	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00327	0.0091	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00308	0.00857	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00304	0.00846	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00255	0.00709	CbGpPWpGaD
Flutamide—AR—Gene Expression—CCAR1—nicotine dependence	0.00252	0.00701	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.0024	0.00668	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00237	0.00659	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00197	0.00547	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00185	0.00516	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00183	0.00508	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP2A7—nicotine dependence	0.00105	0.00291	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000682	0.0019	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000644	0.00179	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000527	0.00147	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000411	0.00114	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000317	0.000882	CbGpPWpGaD
